CS215142B2 - Method of making the solid solvates of the syn-+l2-+l-amino-4-thiazolyl+p-2-methoxyimino+p acetymido-3-acetoxymethyl-3-cefem-4-carboxyl acid with cycling ethers - Google Patents
Method of making the solid solvates of the syn-+l2-+l-amino-4-thiazolyl+p-2-methoxyimino+p acetymido-3-acetoxymethyl-3-cefem-4-carboxyl acid with cycling ethers Download PDFInfo
- Publication number
- CS215142B2 CS215142B2 CS806756A CS675680A CS215142B2 CS 215142 B2 CS215142 B2 CS 215142B2 CS 806756 A CS806756 A CS 806756A CS 675680 A CS675680 A CS 675680A CS 215142 B2 CS215142 B2 CS 215142B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- compound
- acid
- mol
- mixture
- solvate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/02—Preparation
- C07D501/12—Separation; Purification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
- C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/082,822 US4252951A (en) | 1979-10-09 | 1979-10-09 | Isolation of syn-7-(2-amino-4-thiazolyl)-(methoxyimino)acetamido-3-acetoxymethyl-3-cephem-4-carboxylic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
CS215142B2 true CS215142B2 (en) | 1982-07-30 |
Family
ID=22173679
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS806756A CS215142B2 (en) | 1979-10-09 | 1980-10-07 | Method of making the solid solvates of the syn-+l2-+l-amino-4-thiazolyl+p-2-methoxyimino+p acetymido-3-acetoxymethyl-3-cefem-4-carboxyl acid with cycling ethers |
Country Status (27)
Country | Link |
---|---|
US (1) | US4252951A (de) |
EP (1) | EP0027050B1 (de) |
JP (1) | JPS5661388A (de) |
KR (1) | KR840000866B1 (de) |
AT (1) | AT369008B (de) |
AU (1) | AU6306180A (de) |
BE (1) | BE885569A (de) |
CA (1) | CA1146539A (de) |
CH (1) | CH647523A5 (de) |
CS (1) | CS215142B2 (de) |
DD (1) | DD153375A5 (de) |
DE (1) | DE3065181D1 (de) |
DK (1) | DK424680A (de) |
ES (1) | ES8201166A1 (de) |
FI (1) | FI803200L (de) |
FR (1) | FR2467211A1 (de) |
GB (1) | GB2059966B (de) |
GR (1) | GR70219B (de) |
HU (1) | HU183230B (de) |
IE (1) | IE50390B1 (de) |
IL (1) | IL61227A (de) |
IT (1) | IT1132926B (de) |
PH (1) | PH15023A (de) |
PT (1) | PT71886B (de) |
RO (1) | RO80664B (de) |
YU (1) | YU256480A (de) |
ZA (1) | ZA806192B (de) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS588086A (ja) * | 1981-07-07 | 1983-01-18 | Takeda Chem Ind Ltd | セフアロスポリン溶媒和物およびその製造法 |
JPH08831B2 (ja) * | 1985-09-20 | 1996-01-10 | 富山化学工業株式会社 | セファロスポリンの精製法 |
JPH07116200B2 (ja) * | 1985-09-20 | 1995-12-13 | 富山化学工業株式会社 | セファロスポリンの製造方法 |
PL350924A1 (en) * | 1999-04-06 | 2003-02-10 | Sepracor Inc | Derivatives of venlafaxine and methods of preparing and using the same |
US7576198B1 (en) * | 1999-09-02 | 2009-08-18 | Shionogi & Co., Ltd. | Integrase inhibitors containing aromatic heterocycle derivatives |
CA2284459C (en) * | 1999-10-04 | 2012-12-11 | Neokimia Inc. | Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery |
US7151191B2 (en) * | 2000-01-13 | 2006-12-19 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
AU2002326375B2 (en) * | 2001-03-08 | 2006-12-21 | The Trustees Of The University Of Pennsylvania | Facially amphiphilic polymers as anti-infective agents |
NZ531139A (en) * | 2001-08-29 | 2007-09-28 | Neose Technologies Inc | Synthetic ganglioside derivatives and compositions thereof |
EP2617711A1 (de) * | 2002-09-19 | 2013-07-24 | Kyorin Pharmaceutical Co., Ltd. | Aminoalkoholderivate, Salze davon und Immunsuppressiva |
US7056916B2 (en) * | 2002-11-15 | 2006-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
KR101241176B1 (ko) * | 2003-03-17 | 2013-03-13 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 표면적으로 양쪽성인 중합체 및 올리고머 및 이의 용도 |
US7321065B2 (en) * | 2003-04-18 | 2008-01-22 | The Regents Of The University Of California | Thyronamine derivatives and analogs and methods of use thereof |
US20050203184A1 (en) * | 2003-09-10 | 2005-09-15 | Petasis Nicos A. | Benzo lipoxin analogues |
CN1922133A (zh) * | 2004-01-23 | 2007-02-28 | 宾夕法尼亚州大学理事会 | 表面两亲性聚芳基和聚芳基炔基聚合物和低聚物及其用途 |
BRPI0510715A (pt) * | 2004-05-06 | 2007-11-20 | Univ California | enaminonas substituìdas, seus derivados e usos destas |
US7220742B2 (en) * | 2004-05-14 | 2007-05-22 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
US20050255050A1 (en) * | 2004-05-14 | 2005-11-17 | Boehringer Ingelheim International Gmbh | Powder formulations for inhalation, comprising enantiomerically pure beta agonists |
TWI403334B (zh) * | 2004-12-23 | 2013-08-01 | Merck Sharp & Dohme | 包含生物素殘基之抗血栓雙重抑制劑 |
CA2599205A1 (en) * | 2005-02-25 | 2006-09-08 | The Trustees Of The University Of Pennsylvania | Facially amphiphilic polymers and oligomers, compositions thereof, and use thereof in methods of treating cancer |
JP5150807B2 (ja) * | 2005-02-28 | 2013-02-27 | 株式会社明治 | ハイドロキノン長鎖誘導体及び/又はフェノキシ長鎖誘導体及びこれらを含有する医薬 |
CA2619005A1 (en) * | 2005-08-10 | 2007-02-22 | Johns Hopkins University | Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-specific demethylase inhibitors |
PL1917253T3 (pl) * | 2005-08-15 | 2015-06-30 | Boehringer Ingelheim Int | Sposób wytwarzania betamimetyków |
US8592433B2 (en) * | 2005-10-28 | 2013-11-26 | Advait Nagle | Compounds and compositions as protein kinase inhibitors |
EP1954259A2 (de) * | 2005-11-29 | 2008-08-13 | Hammersmith Imanet, Ltd | Amidin-derivate zur darstellung in vivo |
ES2288107B1 (es) * | 2006-01-27 | 2008-11-01 | Fundacion Imabis Instituto Mediterraneo Para El Avance De La Biotecnologia Y La Investigacion Sanita | Derivados aciclicos saturados e insaturados de cadena larga de sulfamidas como activadores especificos de receptores ppar-alfa. |
US20090075935A1 (en) * | 2006-07-03 | 2009-03-19 | L'oreal | Composition comprising at least one c-glycoside derivative and at least one hyaluronic acid and its cosmetic use |
FR2902999B1 (fr) * | 2006-07-03 | 2012-09-28 | Oreal | Utilisation de derives c-glycoside a titre d'actif prodesquamant |
FR2903004B1 (fr) * | 2006-07-03 | 2009-07-10 | Oreal | Utilisation en cosmetique d'un derive c-glycoside en association avec de l'acide ascorbique |
FR2902996B1 (fr) * | 2006-07-03 | 2008-09-26 | Oreal | Compositions cosmetiques associant un derive c-glycoside et un derive n-acylaminoamide |
EA016820B1 (ru) * | 2006-12-14 | 2012-07-30 | Тева Фармасьютикал Индастриз, Лтд. | Кристаллическое твердое основание разагилина |
CN104844678B (zh) | 2007-05-11 | 2018-02-09 | 香港科技大学 | 具有神经保护和增强记忆活性的受体调节剂 |
US7696383B2 (en) * | 2007-06-26 | 2010-04-13 | Solvay Pharmaceuticals B.V. | N-oxides of venlafaxine and o-desmethylvenlafaxine as prodrugs |
FR2920000B1 (fr) * | 2007-08-13 | 2010-01-29 | Oreal | Composition cosmetique ou pharmaceutique contenant de l'acide hyaluronique, et procede cosmetique pour diminuer les signes du vieilissement |
US8692017B2 (en) * | 2007-10-19 | 2014-04-08 | Janssen Pharmaceutica, N.V. | Carbon linked modulators of gamma-secretase |
CN101903347B (zh) * | 2007-10-19 | 2013-03-27 | 詹森药业有限公司 | 带哌啶基和哌嗪基的γ-分泌酶调节剂 |
AU2008312371B2 (en) * | 2007-10-19 | 2013-06-20 | Janssen Pharmaceutica, N.V. | Amine linked modulators of gamma-secretase |
EP2093207A1 (de) * | 2008-02-06 | 2009-08-26 | Julius-Maximilians-Universität Würzburg | Aus tropischen Lianen isolierte antiinfektiöse und antitumorale Verbindungen |
US8063249B1 (en) * | 2008-04-25 | 2011-11-22 | Olema Pharmaceuticals, Inc. | Substituted triphenyl butenes |
WO2010017328A2 (en) * | 2008-08-06 | 2010-02-11 | Rgo Biosciences Llc | Cyclodextrin conjugates |
CA2740952C (en) * | 2008-10-22 | 2015-12-29 | Ian L. Scott | Compounds for treating ophthalmic diseases and disorders |
FR2940610B1 (fr) * | 2008-12-30 | 2011-05-06 | Oreal | Association de monosaccharides avec des derives c-glycosides et son utilisation en cosmetique |
WO2010111530A1 (en) | 2009-03-25 | 2010-09-30 | Seneb Biosciences, Inc. | Glycolipids as treatment for disease |
NZ596470A (en) * | 2009-05-14 | 2014-04-30 | Millennium Pharm Inc | Hydrochloride salt of ((1s,2s,4r)-4-{ 4-[(1s)-2,3-dihydro-1h-inden-1-ylamino]-7h-pyrrolo [2,3-d]pyrimidin-7-yl} -2-hydroxycyclopentyl)methyl sulfamate |
US8962639B2 (en) * | 2009-05-29 | 2015-02-24 | Abbvie Inc. | Potassium channel modulators |
US8288592B2 (en) * | 2009-09-22 | 2012-10-16 | Actavis Group Ptc Ehf | Solid state forms of tapentadol salts |
WO2012067824A1 (en) | 2010-11-16 | 2012-05-24 | Abbott Laboratories | Potassium channel modulators |
BR112014005234A2 (pt) * | 2011-09-06 | 2017-04-11 | Curna Inc | tratamento de doenças relacionadas com subunididades alfa dos canais de sódio dependentes de voltagem (scnxa) com pequenas moléculas |
US8377946B1 (en) | 2011-12-30 | 2013-02-19 | Pharmacyclics, Inc. | Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3925372A (en) * | 1973-02-23 | 1975-12-09 | Lilly Co Eli | Alpha-aminoacyl-3-halo cephalosporins |
DK154939C (da) * | 1974-12-19 | 1989-06-12 | Takeda Chemical Industries Ltd | Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf |
DE2760123C2 (de) * | 1976-01-23 | 1986-04-30 | Roussel-Uclaf, Paris | 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen |
US4166115A (en) * | 1976-04-12 | 1979-08-28 | Fujisawa Pharmaceutical Co., Ltd. | Syn 7-oxoimino substituted derivatives of cephalosporanic acid |
-
1979
- 1979-10-09 US US06/082,822 patent/US4252951A/en not_active Expired - Lifetime
-
1980
- 1980-10-07 FR FR8021431A patent/FR2467211A1/fr active Granted
- 1980-10-07 YU YU02564/80A patent/YU256480A/xx unknown
- 1980-10-07 ZA ZA00806192A patent/ZA806192B/xx unknown
- 1980-10-07 GR GR63068A patent/GR70219B/el unknown
- 1980-10-07 DE DE8080303525T patent/DE3065181D1/de not_active Expired
- 1980-10-07 PT PT71886A patent/PT71886B/pt unknown
- 1980-10-07 JP JP14111980A patent/JPS5661388A/ja active Pending
- 1980-10-07 EP EP80303525A patent/EP0027050B1/de not_active Expired
- 1980-10-07 GB GB8032258A patent/GB2059966B/en not_active Expired
- 1980-10-07 IL IL61227A patent/IL61227A/xx unknown
- 1980-10-07 PH PH24677A patent/PH15023A/en unknown
- 1980-10-07 AT AT0498080A patent/AT369008B/de not_active IP Right Cessation
- 1980-10-07 CA CA000361704A patent/CA1146539A/en not_active Expired
- 1980-10-07 CS CS806756A patent/CS215142B2/cs unknown
- 1980-10-08 KR KR1019800003868A patent/KR840000866B1/ko active
- 1980-10-08 BE BE1/9975A patent/BE885569A/fr not_active IP Right Cessation
- 1980-10-08 IT IT25200/80A patent/IT1132926B/it active
- 1980-10-08 IE IE2086/80A patent/IE50390B1/en unknown
- 1980-10-08 CH CH7518/80A patent/CH647523A5/fr not_active IP Right Cessation
- 1980-10-08 DD DD80224408A patent/DD153375A5/de unknown
- 1980-10-08 DK DK424680A patent/DK424680A/da not_active Application Discontinuation
- 1980-10-08 AU AU63061/80A patent/AU6306180A/en not_active Abandoned
- 1980-10-08 RO RO102315A patent/RO80664B/ro unknown
- 1980-10-08 ES ES495753A patent/ES8201166A1/es not_active Expired
- 1980-10-08 HU HU802455A patent/HU183230B/hu unknown
- 1980-10-09 FI FI803200A patent/FI803200L/fi not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CS215142B2 (en) | Method of making the solid solvates of the syn-+l2-+l-amino-4-thiazolyl+p-2-methoxyimino+p acetymido-3-acetoxymethyl-3-cefem-4-carboxyl acid with cycling ethers | |
FI74019C (fi) | Foerfarande foer framstaellning av 7 -acylamino-3-substitueradmetyl-3-cefem-4-karboxylsyraderivat. | |
KR100442717B1 (ko) | 세프디니르의 결정성 아민 염 | |
JPH02311483A (ja) | セフトリアキソンの製造方法 | |
US4003896A (en) | Method of preparing a sparingly soluble complex of cephalexin | |
JPS6360992A (ja) | 3−置換7−アミノチアゾリルアセトアミドセフアロスポラン酸の新規なオキシム誘導体 | |
US4525587A (en) | Process for preparing a cephalosporin compound | |
SU546282A3 (ru) | Способ получени 7- -амино-7 метокси-цефалоспориновых эфиров | |
JPS6118786A (ja) | セフタジダイムの改良結晶化法 | |
US4904776A (en) | Method for producing crystalline cefadroxil hemihydrate | |
US3507860A (en) | Process for the purification of crude 7-aminocephalosporanic acid and acid addition salts of 7 - amino - cephalosporanic acid employed therein | |
GB2421024A (en) | Cefdinir crystalline form C | |
CA1236089A (en) | Ceftazidime | |
US3284451A (en) | Activated esters of 7-amino-cephalosporanic acid | |
RU2073680C1 (ru) | Кристаллические кислотно-аддитивные соли чистых диастереомеров 1-(2,2-диметилпропионилокси)-этилового эфира 3-цефем-4-карбоновой кислоты и способы их получения | |
US4497956A (en) | Manufacture of antibiotics | |
SU574158A3 (ru) | Способ получени цефалексина или его солей | |
AU728627B2 (en) | Cephalosporin crystals and process for their preparation | |
US4959495A (en) | Process for the preparation of intermediates used to produce aminothiazoloximino cephalosporins | |
FI68239C (fi) | Kristallina 3-hydroxicefalosporinsolvat som aer mellanprodukter vid framstaellning av 3-hydroxicefalosporiner anvaendbara som mellanprodukter vid framstaellning av cefalosporiner ochfoerfarande foer framstaellning av dessa solvat | |
EP1178992A2 (de) | Verfahren zur herstellung von cefpodoxim-säure | |
EP0101148A2 (de) | Thiazolderivat, Verfahren zu seiner Herstellung sowie seine Verwendung bei der Herstellung von Beta-Lactam-Antibiotika | |
JP2661810B2 (ja) | 7−アミノ−3−クロロメチル−3−セフェム誘導体の製法 | |
EP0102687B1 (de) | Verfahren zur Herstellung von 4-Halogen-2-hydroxyimino-acetessigsäureestern | |
JPH06104670B2 (ja) | 化学化合物の新規製法 |